Nytricx Current Funding
- SBIR Phase I "Nitric Oxide Releasing Ultra-Slippery Antibacterial Surfaces for Urological Catheter Applications", $337,395, Period: 2023-2024
- STTR Phase I "Enhanced Prosthetic Vascular Graft Function by Local Release of Nitric Oxide", $306,823, Period: 2024-2025
- STTR Phase II "Ultra-low Fouling, Anti-infective, Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters, $2,350,885, Period: 2023-2025
- CDMRP "Achieving Homeostasis in Traumatic Injuries with a Nitric Oxide-Driven Antimicrobial Dressing Combined with a Rapid Blood Clotting Agent", $1,114,225, Period:2023-2025
- BARDA "Prevention of ECMO Circuit Thrombosis and Infection by Surface Release of Nitric Oxide" $749,973, Period 2024-2025
